... ratio of 0.81. Several institutional investors have recently added to or reduced their stakes in the business. Ardsley Advisory Partners bought a new position in shares of Eiger Biopharmaceuticals during the 2nd quarter valued at approximately ...
https://www.americanbankingnews.com/2018/08/15/q3-2018-eps-estimates-for-eiger-biopharmaceuticals-inc-lowered-by-b-riley-eigr.html
No comments:
Post a Comment